Browsing by Author Sjoquist, Katrin

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 17 of 17
Issue DateTitleAuthor(s)Citation
2016Advances in Molecular Pathology and Treatment of Periampullary CancersPrice, Timothy; Sjoquist, Katrin; Chandrasegaram, Manju D; Chen, John; Merrett, Neil D; Price, Timothy; Zalcberg, John; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreAdvances in Molecular Pathology and Treatment of Periampullary Cancers, Pancreas, vol.45, 1, 2016,pp 32-39
2013Clinical Trials - Advancing National Cancer CareSjoquist, Katrin; Zalcberg, John; School of Public Health: NH&MRC Clinical Trials CentreClinical Trials - Advancing National Cancer Care, Cancer Forum, vol.37, 1, 2013,pp 80-87
2015Clinical utility of ramucirumab in advanced gastric cancerChan, Matthew; Sjoquist, Katrin; Zalcberg, John; Northern Clinical School: Melanoma Institute of Australia; NH&MRC Clinical Trials CentreClinical utility of ramucirumab in advanced gastric cancer, Biologics (Print): targets & therapy, vol.9, N/A, 2015,pp 93-105
2014Development of the Measure of Ovarian Symptoms and Treatment Concerns: Aiming for Optimal Measurement of Patient-Reported Symptom Benefit with Chemotherapy for Symptomatic Ovarian CancerButow, Phyllis; Friedlander, Michael; Gillies, Kim Michelle; King, Madeleine; Martyn, Julie; Mercieca-Bebber, Rebecca; O'Connell, Rachel; Sjoquist, Katrin; Stockler, Martin; Voysey, Merryn; Donovan, Heidi; Oza, Amit; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreDevelopment of the Measure of Ovarian Symptoms and Treatment Concerns: Aiming for Optimal Measurement of Patient-Reported Symptom Benefit with Chemotherapy for Symptomatic Ovarian Cancer, International Journal of Gynecological Cancer, vol.24, 5, 2014,pp 865-873
2015Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumabGebski, Val; Price, Timothy; Sjoquist, Katrin; et al, Various; Field, Kathryn; Gibbs, Peter; McKendrick, J; Nott, Louise M; Roohullah, Aflah; Shapiro, Jeremy; Tran, Ben; Wong, Hui-Li; Yip, Desmond; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreGastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab, World Journal of Gastroenterology, vol.21, 17, 2015,pp 5352-5358
2013Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecological Cancer Intergroup Symptom Benefit StudyButow, Phyllis; Friedlander, Michael; Gillies, Kim Michelle; King, Madeleine; Martyn, Julie; O'Connell, Rachel; Sjoquist, Katrin; Stockler, Martin; Voysey, Merryn; Oza, Amit; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreHope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecological Cancer Intergroup Symptom Benefit Study, The Oncologist, vol.18, 11, 2013,pp 1221-1228
2013Hormonal Treatment in Recurrent and Metastatic Gynaecological Cancers: A Review of the Current LiteratureFriedlander, Michael; Sjoquist, Katrin; Sommeijer, Dirkje; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreHormonal Treatment in Recurrent and Metastatic Gynaecological Cancers: A Review of the Current Literature, Current Oncology, vol.15, 6, 2013,pp 541-548
2011Overview of controversies in oesophagogastric cancerCameron, Andrew; Sjoquist, Katrin; Zalcberg, John; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreOverview of controversies in oesophagogastric cancer, Cancer Forum, vol.35, 3, 2011,pp 139-141
2016Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trialFerraro, Danielle Angela; Gebski, Val; Hall, Merryn; Pavlakis, Nick; Sjoquist, Katrin; Veillard, Anne-Sophie; Wong, Nicole; Cooray, Prasad; Ganju, V.; Price, Timothy; Shannon, Jenny; Strickland, A. H.; Tebbutt, Niall; Underhill, Craig; Varma, S; Young, Rosemary; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentrePanitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial, British Journal of Cancer, vol.114, 5, 2016,pp 505-509
2017Paragon (ANZGOG-0903): Phase 2 study of anastrozole in women with estrogen or progesterone receptorypositive platinum-resistant or -refractory recurrent ovarian cancerBeale, Philip; deFazio, Anna; Friedlander, Michael; Mapagu, Cristina; Martyn, Julie; Mileshkin, Linda; O'Connell, Rachel; Sjoquist, Katrin; Bonaventura, Anthony; Goh, J; Grant, Peter; Hadley, Alison; McNally, Orla; Scurry, James P; Central Clinical School: Medicine; Western Clinical School: Westmead Institute for Medical Res; NH&MRC Clinical Trials Centre; Childrens Hospital Westmead: Paediatrics & Child Health; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreParagon (ANZGOG-0903): Phase 2 study of anastrozole in women with estrogen or progesterone receptorypositive platinum-resistant or -refractory recurrent ovarian cancer, International Journal of Gynecological Cancer, vol.27, 5, 2017,pp 900-906
2014Personalising pancreas cancer treatment: When tissue is the issueSjoquist, Katrin; Biankin, Andrew; Chang, David K.; Chantrill, L; Chin, Venessa; Chou, Angela; Hemmings, Chris; Johns, Amber L; Nagrial, Adnan; OConnor, Chelsie; Pajic, Marina; Yip, Desmond; School of Public Health: NH&MRC Clinical Trials CentrePersonalising pancreas cancer treatment: When tissue is the issue, World Journal of Gastroenterology, vol.20, 24, 2014,pp 7849-7863
2015Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) TrialChin, Venessa; Gill, Anthony; Grimison, Peter; Nagrial, Adnan; Pavlakis, Nick; Samra, Jaswinder; Sebastian, Lucille; Simes, Robert John; Sjoquist, Katrin; Yip, Sonia; Asghari, R; Biankin, Andrew; Brown, Belinda; Chang, David; Chantrill, Lorraine; Chou, Angela; Grimmond, Sean; Harvey, Sandra L; Humphris, Jeremy; Johns, Amber L; Jones, Mark D; Martyn-Smith, Mona; Mead, Scott; Morey, Adrienne; Pajic, Marina; Simpson, Skye H; Thomas, David; Watson, Clare; Watson, Nicole; Central Clinical School: Medicine; Northern Clinical School: Pathology; NH&MRC Clinical Trials Centre; Medicine; Northern Clinical School: Medicine; Northern Clinical School: Surgery; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentrePrecision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial, Clinical Cancer Research, vol.21, 9, 2015,pp 2029-2037
2016Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II TrialMartin, Andrew; Pavlakis, Nick; Simes, Robert John; Sjoquist, Katrin; Tsobanis, Eric; Wong, Ka (Mark); Yip, Sonia; Alcindor, Thierry; bang, Yungjue; Burnell, Margot J; Cho, Jaeyong; Goldstein, David; Kang, Yoon-Koo; Kim, Jinwon; Lee, Jeeyun; Lipton, Lara; O'Callaghan, Chris; Rha, Sunyoung; Strickland, A. H.; Tebbutt, Niall; Zalcberg, John; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); NH&MRC Clinical Trials CentreRegorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial, Journal of Clinical Oncology, vol.34, 23, 2016,pp 2728-2735
2011The role of hormonal therapy in gynecological cancers-current status and future directionsMartyn, Julie; Sjoquist, Katrin; Edmondson, Richard; Friedlander, Michael; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreThe role of hormonal therapy in gynecological cancers-current status and future directions, International Journal Of Gynecological Cancer, vol.21, 7, 2011,pp 1328-1333
2015Second-line treatment in inoperable pancreatic adenocarcinoma: A systematic review and synthesis of all clinical trialsHorvath, Lisa; Sjoquist, Katrin; Biankin, Andrew V.; Chin, Venessa; Nagrial, Adnan; Pajic, Marina; Yip, Desmond; Central Clinical School: Medicine; NH&MRC Clinical Trials CentreSecond-line treatment in inoperable pancreatic adenocarcinoma: A systematic review and synthesis of all clinical trials, Critical Reviews in Oncology / Hematology (online), vol.96, 3, 2015,pp 483-497
2011Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysisGebski, Val; Simes, Robert John; Sjoquist, Katrin; Barbour, Andrew; Burmeister, Bryan H.; Smithers, Bernard Mark; Zalcberg, John; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSurvival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis, Lancet Oncology, vol.12, 7, 2011,pp 681-692
2014Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit studyButow, Phyllis; Friedlander, Michael; Gillies, Kim Michelle; King, Madeleine; Martyn, Julie; O'Connell, Rachel; Sjoquist, Katrin; Stockler, Martin; Voysey, Merryn; Donovan, Heidi; Oza, Amit; Symptom Benefit Study Group, .; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Psychology; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreSymptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the gynecologic cancer intergroup symptom benefit study, International Journal of Gynecological Cancer, vol.24, 5, 2014,pp 857-864